Exosomes isolated from ascites of T-cell lymphoma-bearing mice expressing surface CD24 and HSP-90 induce a tumor-specific immune response

Frontiers in Immunology

Volumn 8, Issue MAR, 2017, Pages

  Menay, Florencia ^a   Herschlik, Leticia ^a   De Toro, Julieta ^a   Cocozza, Federico ^a   Tsacalian, Rodrigo ^a   Gravisaco, María José ^b   Di Sciullo, María Paula ^a   Vendrell, Alejandrina ^a   Waldner, Claudia I ^a   Mongini, Claudia ^a,b  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Ascites; Exosomes; Immune response; T cell lymphoma; Tumor vaccine

Indexed keywords

ALIX PROTEIN; CARBOXYFLUORESCEIN SUCCINIMIDYL ESTER; CD24 ANTIGEN; CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; FLUORESCENT DYE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; PEPTIDES AND PROTEINS; TETRASPANIN; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ASCITES; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DOT HYBRIDIZATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMALE; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOLOGICAL MEMORY; ISOLATION PROCEDURE; MOUSE; NONHUMAN; SPLEEN CELL; T CELL LYMPHOMA; TUMOR IMMUNITY; TUMOR REJECTION; ULTRACENTRIFUGATION; ULTRAFILTRATION; VACCINATION; WESTERN BLOTTING;

EID: 85017184464     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00286     Document Type: Article

References (41)

1. El Andaloussi S, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 12:347-57. doi: 10.1038/nrd3978
2. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol (2014) 30:255-89. doi:10.1146/annurev-cellbio-101512-122326
3. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A (2016) 113:E968-77. doi:10.1073/pnas.1521230113
4. De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol (2015) 6:203. doi:10.3389/fimmu.2015.00203
5. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144:646-74. doi:10.1016/j.cell.2011.02.013
6. Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (2013) 91:431-7. doi:10.1007/s00109-013-1020-6
7. Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringnér M, et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A (2013) 110:7312-7. doi:10.1073/pnas.1220998110
8. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res (2010) 70:9621-30. doi:10.1158/0008-5472.CAN-10-1722
9. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol (2014) 14:195-208. doi:10.1038/nri3622
10. Le Pecq J-B. Dexosomes as a therapeutic cancer vaccine: from bench to bedside. Blood Cells Mol Dis (2005) 35:129-35. doi:10.1016/j.bcmd.2005.06.003
11. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, et al. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis (2005) 35:169-73. doi:10.1016/j.bcmd.2005.07.001
12. Klibi J, Niki T, Riedel A, Pioche-Durieu C, Souquere S, Rubinstein E, et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood (2009) 113:1957-66. doi:10.1182/blood-2008-02-142596
13. Valenti R, Huber V, Iero M, Filipazzi P, Parmiani G, Rivoltini L. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res (2007) 67:2912-5. doi:10.1158/0008-5472.CAN-07-0520
14. Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res (2007) 67:7458-66. doi:10.1158/0008-5472.CAN-06-3456
15. Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol (2006) 176:1375-85. doi:10.4049/jimmunol.176.3.1375
16. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One (2010) 5:e11469. doi:10.1371/journal.pone.0011469
17. Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, et al. Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunol Immunother (2011) 60(5):639-48. doi:10.1007/s00262-011-0979-5
18. Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med (2005) 3:9. doi:10.1186/1479-5876-3-9
19. Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther (2008) 16:782-90. doi:10.1038/mt.2008.1
20. Clayton A, Mason MD. Exosomes in tumour immunity. Curr Oncol (2009) 16:46-9. doi:10.3747/co.v16i3.367
21. Rialland P, Lankar D, Raposo G, Bonnerot C, Hubert P. BCR-bound antigen is targeted to exosomes in human follicular lymphoma B-cells. Biol Cell (2006) 98:491-501. doi:10.1042/BC20060027
22. Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A (2011) 108:15336-41. doi:10.1073/pnas.1102855108
23. Vallhov H, Gutzeit C, Johansson SM, Nagy N, Paul M, Li Q, et al. Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J Immunol (2011) 186:73-82. doi:10.4049/jimmunol.1001145
24. Mongini C, Ruybal P, Gravisaco MJ, Croci M, Sánchez Lockhart M, Fabris V, et al. Characterization of the immunophenotype and the metastatic properties of a murine T-lymphoma cell line. Unexpected expression of cytoplasmatic CD4. In Vitro Cell Dev Biol Anim (2001) 37:499-504. doi:10.1290/1071-2690(2001)037<0499:COTIAT>2.0.CO;2
25. Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants. Curr Protoc Cell Biol (2006) 3.22.1-3.22.29. doi:10.1002/0471143030.cb0322s30
26. Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods (2001) 247:163-74. doi:10.1016/S0022-1759(00)00321-5
27. Ruybal P, Gravisaco MJ, Barcala V, Escalada A, Cremaschi G, Taboga O, et al. Transgene expression enhancement in T-lymphoma cell lines. Int Immunopharmacol (2005) 5:1685-92. doi:10.1016/j.intimp.2005.04.016
28. Vendrell A, Gravisaco MJ, Pasetti MF, Croci M, Colombo L, Rodríguez C, et al. A novel Salmonella typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer. Vaccine (2011) 29:728-36. doi:10.1016/j.vaccine.2010.11.017
29. Quah BJC, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc (2007) 2:2049-56. doi:10.1038/nprot.2007.296
30. Lamoreaux L, Roederer M, Koup R. Intracellular cytokine optimization and standard operating procedure. Nat Protoc (2006) 1:1507-16. doi:10.1038/nprot.2006.268
31. Vendrell A, Gravisaco MJ, Goin JC, Pasetti MF, Herschllik L, De Toro J, et al. Therapeutic effects of Salmonella typhi in a mouse model of T-cell lymphoma. J Immunother (2013) 36:171-80. doi:10.1097/CJI.0b013e3182886d95
32. Gould SJ, Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles (2013) 2:20389-91. doi:10.3402/jev.v2i0.20389
33. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol (2002) 2:569-79. doi:10.1038/nri855
34. Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LAA, et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol (2004) 31(1):114-21. doi:10.1165/rcmb.2003-0238OC
35. Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, et al. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis. Cancer Res (2005) 65:10783-93. doi:10.1158/0008-5472.CAN-05-0619
36. Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci (2005) 118:3631-8. doi:10.1242/jcs.02494
37. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 200:373-83. doi:10.1083/jcb.201211138
38. Skokos D, Botros HG, Demeure C, Morin J, Peronet R, Birkenmeier G, et al. Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo. J Immunol (2003) 170:3037-45. doi:10.4049/jimmunol.170.6.3037
39. Spisek R, Charalambous A, Mazumder A, Vesole HD, Jagannath S, Dhodapkar VM. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood (2007) 109:4839-45. doi:10.1182/blood-2006-10054221
40. Ahmed N, Stenvers KL. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol (2013) 3:256. doi:10.3389/fonc.2013.00256
41. Andre F, Schartz NEC, Movassagh M, Flament C, Pautier P, Morice P, et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet (2002) 360:295-305. doi:10.1016/S0140-6736(02)09552-1